IQVIA Biotech’s Post

From planning and logistics to regulatory approvals and patient recruitment, immuno-oncology (IO) therapies pose unique challenges in clinical research. Discover how IQVIA Biotech’s cutting-edge approach helps biotech and emerging biopharma companies to successfully navigate IO trials and advance cancer treatments. https://bit.ly/3Bk4UmT #clinicalresearch #immunooncology

Enhancing research efficiency is crucial for breakthrough cancer therapies. Learn how Genmab improved data access, analysis, and visualization with Certara's SEND Explorer web-based tool for non-clinical study data analysis, boosting their non-clinical drug development. Read the full case study: https://ow.ly/lOmM50TeWvz #Certara #Genmab #FutureOfPharma #PharmaceuticalInnovation #DrugDevelopment #CancerResearch #DataManagement #SENDStandards #DataDriven #Nonclinical #PharmaceuticalResearch #AntibodyDrugConjugates #ComplexToxicologyData

LucidQuest Views >>> How a mid-size pharma in the prostate cancer space used insights to adapt its drug development program and marketing efforts. #Casestudies #casestudy #ourwork Comment below! >>> lqventures.com

LucidQuest Views >>> How a mid-size pharma in the prostate cancer space used insights to adapt its drug development program and marketing efforts. #Casestudies #casestudy #ourwork Comment below! >>> lqventures.com

📣 Calling all Supply Chain and Clinical Operations Specialists! ⏳ The $600 early-registration deadline for the 5th Supply Chain & Logistics for Cell Therapy Summit will expire this Friday, 9th of February. Make sure you don't miss out on your chance to save and click here to download the full event guide and learn how to save on this event: https://ter.li/c0vzh9 As the cell therapy industry takes strides to revolutionize supply chains ready to scale trials through 2024 and beyond, we are excited to this year unite AstraZeneca, BeBiopharma, Carisma Therapeutics, Celularity, Mustang Bio, Moffitt Cancer Centre, and many more to delve into key topics including: 📈 Cost-effective methods to dismantle scale-up bottlenecks. 💻 Utilizing Automated Systems to track the Chain of Custody & Identity more accurately and effectively. 🌐 Evolving the Supply Chain from Clinical to Commercial Phase. 🏥 Improving Patient Uptake for Trials to increase Time Efficiency. For further information, please email: [email protected] #cellandgene #supplychain #logistics #celltherapies #cryopreservation #clinicaltrialmanagement #clinicaloperations #immunology #scaleup

From lab to market, a new drug's journey can take up to 15 years—often coming across several hurdles and failure points. As a result, many never reach the approval stage for human use. 🧪💊 For more than 20 years, we’ve been making the drug development process faster, cheaper and more predictable. We work with partners to solve real development and real-world treatment challenges and excel in combining knowledge of cancer with cutting-edge mathematics to develop models that help accelerate pre-clinical and clinical development. Our expert team has successfully completed 100+ projects, modelled 50+ targets, and advanced 75 drugs across various therapeutic areas. Ready to de-risk your drug development journey? Contact us today: https://lnkd.in/eYmCKgmX #Cancer #DrugDevelopment #VirtualTumour #Immunotherapy #CancerDrugs #CancerSimulation #CombinationTherapies #QSP #MathematicalModelling #PKPD #MechanisticModelling #Oncology #ClinicalTrials #ResearchandDevelopment #CancerResearch #BioTech #StatisticalModelling #MachineLearning #Pharma #PYC

🔬 For over 20 years, we've been transforming drug development with cutting-edge mathematics and expertise in cancer research. Specialising in sophisticated modelling, we accelerate the complex stages of drug development from pre-clinical to clinical phases. With over 100 projects completed, 50+ targets modelled and 75 drugs advanced across various therapeutic areas, our expert team delivers proven results.💡 🦾 Our approach minimises reliance on time-consuming lab work and animal studies, ensuring you get it right the first time. Ready to de-risk your drug development journey? Reach out to our team! https://lnkd.in/eYmCKgmX #Cancer #DrugDevelopment #CancerDrugs #CancerSimulation #CombinationTherapies #QSP #MathematicalModelling #PKPD #MechanisticModelling #Oncology #ClinicalTrials #ResearchandDevelopment #CancerResearch #BioTech #StatisticalModelling #MachineLearning #Pharma #TranslationalModelling #PYC

ICYMI: LucidQuest Views >>> How a mid-size pharma in the prostate cancer space used insights to adapt its drug development program and marketing efforts. #Casestudies #casestudy #ourwork Comment below! >>> lqventures.com

FYI: LucidQuest Views >>> How a mid-size pharma in the prostate cancer space used insights to adapt its drug development program and marketing efforts. #Casestudies #casestudy #ourwork Comment below! >>> lqventures.com

ICYMI: LucidQuest Views >>> How a mid-size pharma in the prostate cancer space used insights to adapt its drug development program and marketing efforts. #Casestudies #casestudy #ourwork Comment below! >>> lqventures.com